LCH-IV INTERNATIONAL COLLABORATIVE TREATMENT PROTOCOL FOR CHILDREN AND ADOLESCENTS WITH LANGERHANS CELL HISTIOCYTOSIS

Registry ID

LCH-IV

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

C17 COUNCIL

Start date

2021-01-05

Last update

2013-09-12

Conditions

• LANGERHANS CELL HISTIOCYTOSIS

Related clinical trials

• PHASE 2 STUDY OF TOVORAFENIB (DAY101) IN RELAPSED AND REFRACTORY LANGERHANS CELL HISTIOCYTOSIS

View on source registry